resveratrol has been researched along with Carcinoma, Non-Small Cell Lung in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.41) | 29.6817 |
| 2010's | 17 (62.96) | 24.3611 |
| 2020's | 8 (29.63) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, P; Ren, G | 1 |
| Fan, Y; Li, J; Liu, Y; Ma, M; Yu, Y; Zhang, Y | 1 |
| Abbaspour-Ravasjani, S; Asadollahi, L; Dorreyatim, SS; Hamishehkar, H; Mahoutforoush, A; Paiva-Santos, AC; Peixoto, D; Soltanfam, T; Veiga, F; Zeinali, M | 1 |
| Guangjian, Z; Jin, Z; Jizhao, W; Meihe, L; Minchao, K; Rui, Z; Shan, G | 1 |
| Al Hroot, J; Al-Husein, B; Mayyas, A; Zayed, A | 1 |
| Bozok Cetintas, V; Duzgun, Z; Erdem, C; Eroglu, Z; Oktem, G | 1 |
| Gupta, V; Kanabar, DD; Muth, A; Parvathaneni, V; Shukla, SK; Wang, X | 1 |
| Gupta, V; Kulkarni, NS; Kunda, NK; Muth, A; Parvathaneni, V; Shukla, SK; Wang, X | 1 |
| Chen, HJ; Chen, RS; Chiu, HC; Huang, YC; Huang, YJ; Jian, YJ; Ko, JC; Lee, WT; Lin, YW; Tseng, SC; Wo, TY | 1 |
| Luo, H; Schulte, BA; Tang, S; Wang, GY; Wang, L; Yang, A | 1 |
| Celik, S; Gunay, E; Hazman, O; Koyuncu, T; Ozdemir, M; Ozyurek, A; Ulasli, SS; Unlu, M | 1 |
| Bai, T; Dong, DS; Pei, L | 1 |
| Chiu, JF; Li, G; Ma, K; Qi, T; Wei, X; Zhang, J; Zhang, Q | 1 |
| Hoti, SL; Karthikeyan, S; Prasad, NR | 1 |
| Hou, B; Hu, W; Nie, P; Yang, Y; Zhang, T; Zou, Z | 1 |
| Chang, PY; Chen, CY; Chen, JC; Jian, YJ; Jian, YT; Ko, JC; Lin, YW; Syu, JJ; Wang, TJ | 1 |
| Jin, F; Li, W; Liu, W; Ma, L; Nan, Y; Wang, Q; Wang, R | 1 |
| Chen, H; Gao, X; He, W; Li, B; Mei, C; Xu, R; Zhu, Y | 1 |
| Jeong, JH; Kim, WY; Kim, Y; Lee, H; Ryu, JH | 1 |
| Dong, Q; Li, N; Li, W; Liang, Q; Liu, H; Liu, Y; Ma, X; Rong, P; Song, W; Tan, S; Wang, W; Xu, C; Yang, C; Zhang, J; Zhang, S | 1 |
| Chen, J; Li, X; Shi, T; Wang, D; Zhao, QC | 1 |
| Hu, LL; Li, ZP; Liu, J; Wang, AW; Wang, ZD; Zhao, QS | 1 |
| Charles, AL; Chen, WC; Chen, YH; Chen, YL; Chong, IW; Chou, SH; Hung, CY; Hwang, JJ; Lin, FY; Liu, PL; Ping, YH; Tsai, JR | 1 |
| An, S; Bae, S; Cha, HJ; Jeung, HK; Kim, J; Kim, K; Kim, YJ; Lee, EM; Lee, H; Lee, HG; Min, YH; Yoon, Y | 1 |
| Chen, H; Chen, X; Liu, G; Tang, L; Wang, H; Wu, C; Yang, Y; Zhang, H; Zhao, M | 1 |
| Chen, YJ; Chen, YY; Kuo, CD; Liao, HF; Lin, CP; Tai, HC; Yang, YC | 1 |
| Becker, K; Hu, Y; Mersch-Sundermann, V; Rahlfs, S | 1 |
27 other study(ies) available for resveratrol and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Identification of potential target genes of non-small cell lung cancer in response to resveratrol treatment by bioinformatics analysis.
Topics: A549 Cells; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; CD13 Antigens; Computational Biology; Databases, Genetic; Humans; Lung Neoplasms; Protein Interaction Maps; Resveratrol; Signal Transduction | 2021 |
Resveratrol Induces Autophagy and Apoptosis in Non-Small-Cell Lung Cancer Cells by Activating the NGFR-AMPK-mTOR Pathway.
Topics: AMP-Activated Protein Kinases; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Humans; Lung Neoplasms; Nerve Tissue Proteins; Receptor, Nerve Growth Factor; Receptors, Nerve Growth Factor; Resveratrol; RNA, Messenger; Signal Transduction; TOR Serine-Threonine Kinases | 2022 |
Co-Delivery of erlotinib and resveratrol via nanostructured lipid Carriers: A synergistically promising approach for cell proliferation prevention and ROS-Mediated apoptosis activation.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Carriers; Erlotinib Hydrochloride; Humans; Lipids; Lung Neoplasms; Nanostructures; Particle Size; Reactive Oxygen Species; Resveratrol | 2022 |
Resveratrol improves the cytotoxic effect of CD8 +T cells in the tumor microenvironment by regulating HMMR/Ferroptosis in lung squamous cell carcinoma.
Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; CD8-Positive T-Lymphocytes; Ferroptosis; Humans; Lung; Lung Neoplasms; Resveratrol; Tumor Microenvironment | 2023 |
Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinib.
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Microsomes, Liver; Rats; Resveratrol | 2023 |
Effect of SIRT1 activators and inhibitors on CD44+/CD133+‑enriched non‑small cell lung cancer cells.
Topics: A549 Cells; AC133 Antigen; Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma, Non-Small-Cell Lung; Heterocyclic Compounds, 4 or More Rings; Humans; Hyaluronan Receptors; Lung Neoplasms; Naphthols; Neoplastic Stem Cells; Resveratrol; Sirtuin 1 | 2020 |
Cyclodextrin Complexation for Enhanced Stability and Non-invasive Pulmonary Delivery of Resveratrol-Applications in Non-small Cell Lung Cancer Treatment.
Topics: Administration, Inhalation; Biological Availability; Carcinoma, Non-Small-Cell Lung; Cyclodextrins; Drug Carriers; Drug Stability; Humans; Lung; Lung Neoplasms; Resveratrol; Solubility | 2020 |
Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer.
Topics: A549 Cells; Administration, Inhalation; beta-Cyclodextrins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Stability; HEK293 Cells; Humans; Lung Neoplasms; Nanoparticles; Particle Size; Resveratrol | 2020 |
Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; DNA Repair; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Endonucleases; Enzyme Activation; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Glutamates; Guanine; Humans; Lung Neoplasms; MAP Kinase Kinase 3; MAP Kinase Kinase 6; p38 Mitogen-Activated Protein Kinases; Pemetrexed; Protein Kinase Inhibitors; Resveratrol; RNA Interference; RNA, Messenger; Signal Transduction; Stilbenes; Time Factors; Transfection | 2013 |
Resveratrol enhances ionizing radiation-induced premature senescence in lung cancer cells.
Topics: Acetylcysteine; Antioxidants; Apoptosis; beta-Galactosidase; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cellular Senescence; DNA Breaks, Double-Stranded; Humans; Lung Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Radiation-Sensitizing Agents; Reactive Oxygen Species; Resveratrol; Ribonucleotide Reductases; Stilbenes; TOR Serine-Threonine Kinases | 2013 |
Anticancer effects of thymoquinone, caffeic acid phenethyl ester and resveratrol on A549 non-small cell lung cancer cells exposed to benzo(a)pyrene.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Benzo(a)pyrene; Benzoquinones; Caffeic Acids; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cytokines; Glutathione; Humans; Lung Neoplasms; Malondialdehyde; NF-kappa B; Nitric Oxide; Phenylethyl Alcohol; Real-Time Polymerase Chain Reaction; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Cells, Cultured | 2013 |
Synergistic antitumor activity of resveratrol and miR-200c in human lung cancer.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; MAP Kinase Signaling System; Mice; Mice, Nude; MicroRNAs; Neoplasm Transplantation; Resveratrol; Ribonucleotide Reductases; Stilbenes; Transfection; Transplantation, Heterologous | 2014 |
P62 regulates resveratrol-mediated Fas/Cav-1 complex formation and transition from autophagy to apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Carcinoma, Non-Small-Cell Lung; Caveolin 1; Cell Line, Tumor; Cell Proliferation; fas Receptor; Humans; Lung Neoplasms; Resveratrol; RNA-Binding Proteins; Stilbenes; Transfection | 2015 |
Resveratrol loaded gelatin nanoparticles synergistically inhibits cell cycle progression and constitutive NF-kappaB activation, and induces apoptosis in non-small cell lung cancer cells.
Topics: Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cattle; Cell Cycle; Cell Line, Tumor; Drug Synergism; Gelatin; Humans; Lung Neoplasms; Mice; Nanoparticles; NF-kappa B; Resveratrol; Stilbenes | 2015 |
Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Line, Tumor; Down-Regulation; Drug Synergism; Erlotinib Hydrochloride; Humans; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Resveratrol; Ribosomal Protein S6 Kinases; Signal Transduction; Stilbenes; Survivin; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53; Up-Regulation | 2015 |
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphorylation; Proto-Oncogene Proteins c-akt; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Time Factors; Transfection; X-ray Repair Cross Complementing Protein 1 | 2015 |
Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Survival; Cisplatin; Flow Cytometry; Humans; Lung Neoplasms; Mitochondria; Resveratrol; Stilbenes | 2015 |
Resveratrol overcomes gefitinib resistance by increasing the intracellular gefitinib concentration and triggering apoptosis, autophagy and senescence in PC9/G NSCLC cells.
Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Autophagy; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cytochrome P-450 CYP1A1; Drug Resistance, Neoplasm; Drug Synergism; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Quinazolines; Resveratrol; Stilbenes | 2015 |
ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.
Topics: Antineoplastic Agents, Phytogenic; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Checkpoint Kinase 1; Checkpoint Kinase 2; Humans; Lung Neoplasms; Proteome; Respiratory Mucosa; Resveratrol; Rheum; Signal Transduction; Stilbenes; Tumor Suppressor Protein p53 | 2016 |
Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Glycolysis; Hexokinase; Humans; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Resveratrol; Signal Transduction; Stilbenes | 2016 |
Resveratrol Inhibited Non-small Cell Lung Cancer Through Inhibiting STAT-3 Signaling.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Gene Transfer Techniques; Humans; Lung Neoplasms; Resveratrol; STAT3 Transcription Factor; Stilbenes | 2016 |
Resveratrol-loaded folic acid-grafted dextran stearate submicron particles exhibits enhanced antitumor efficacy in non-small cell lung cancers.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Dextrans; Drug Liberation; Folic Acid; Humans; Lung Neoplasms; Mitochondria; Particle Size; Resveratrol; Stilbenes; Tumor Suppressor Protein p53 | 2017 |
Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Gene Silencing; Heme Oxygenase-1; Humans; Lung Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Neoplasm Invasiveness; NF-kappa B; Osmolar Concentration; Resveratrol; RNA, Small Interfering; Signal Transduction; Stilbenes | 2010 |
Resveratrol alters microRNA expression profiles in A549 human non-small cell lung cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; MicroRNAs; Oligonucleotide Array Sequence Analysis; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2011 |
Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Topics: Antineoplastic Agents, Phytogenic; Cadherins; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Fibronectins; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Resveratrol; Stilbenes; Transforming Growth Factor beta1; Vimentin | 2013 |
Resveratrol enhances radiosensitivity of human non-small cell lung cancer NCI-H838 cells accompanied by inhibition of nuclear factor-kappa B activation.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Humans; NF-kappa B; Radiation Dosage; Radiation Tolerance; Radiation-Sensitizing Agents; Resveratrol; Stilbenes | 2005 |
Resveratrol modulates mRNA transcripts of genes related to redox metabolism and cell proliferation in non-small-cell lung carcinoma cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Count; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Glutathione; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Humans; Lung Neoplasms; Oxidation-Reduction; Phosphotransferases; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sensitivity and Specificity; Stilbenes; Structure-Activity Relationship; Transcription, Genetic; Tumor Cells, Cultured | 2007 |